Viglita™
Vildagliptin
DPP-4 Inhibitor (Antidiabetic Preparations)
Indication:
ViglitaTM is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus.
Dosage & Administration:
The recommended dose of ViglitaTM is 50 mg or 100 mg daily for monotherapy; 50 mg twice daily (morning and evening) when used in dual combination with Metformin or a Thiazolidinedione; 50 mg once daily in the morning when used in dual combination with a Sulphonylurea.
Preparation:
- ViglitaTM 50 Tablet: Each box contains 20 tablets in a blister pack.
Related Medicine: Xenole™, Xenole™, Vilanti™ Cozycap, Vonokit™, Virux Tablet®,Waxnil™
